The programme targets innovations for heavy menstrual bleeding in low-resource settings, which aligns with the applicant's Nigeria-focused digital health infrastructure. However, the venture is a general e-pharmacy/telepharmacy platform, not specifically focused on HMB, so fit is partial. The regulatory and pharmacist-led approach could be relevant if adapted to HMB care pathways.